HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > RNCOS

Print e mail rss del Y! myWeb Tweet
 

Investments in German Pharma Continue to Surge

Increasing private investments in manufacturing and research services are anticipated to drive the future growth of the German pharma market, predicts a new study by RNCOS.

 



(EMAILWIRE.COM, May 28, 2010 ) New Delhi, India - Germany is considered as one of the most advanced pharma markets in the world. The country is now on the radar of global pharma majors and most of these are looking to expand their operations in the country. The country’s strong research and development infrastructure has also attracted lot of investors to the country. This has boosted the growth of German pharma market. As per our new research on the sector called “German Pharma Sector Analysis”, the pharma market in Germany is projected to grow at a CAGR of around 5% during 2010-2012.

Generics dominate the German pharmaceutical market at present. We have found that Germany pharma is one of most generics-friendly market in the world and more than two-thirds of total prescriptions in the country are of generic drugs. It has been seen that branded drugs loose almost their complete share in the market to the generics version just after few months of patent expiration. In this regard, our report provides a complete analysis of the German generic drugs industry.

Apart from this, we have studied all the company-level trends prevailing in the industry and our research report provides complete analysis of these existing trends. We believe that regulatory environment plays an important role in the development of pharma market and thus, our research report provides complete detail of the pharma regulatory environment in the country. The report also provides information on various government steps and initiatives that have been taken to improve the growth of the pharma market.

“German Pharma Sector Analysis” is an outcome of our extensive research and in-depth analysis. The report provides various industry forecasts, which are completely based on our various in-house statistical models. Moreover, it also provides information on various key players highlighting their strengths and weaknesses. Thus, the report presents a clear and unbiased picture of the German pharma market to clients and helps them in making smart and intelligent investment decisions.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM253.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com

About RNCOS:

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.

Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012